AI tools for infectious disease: stewardship, micro lab, and CDS
ID AI tools have moved beyond press releases. Here’s the directory of tools with active hospital deployments.
Tag: physician finance
Antimicrobial stewardship consulting: side income for ID physicians
ID physicians have unique consulting opportunities — antimicrobial stewardship, hospital epi, FDA work. Here’s how to structure 1099 income.
Real estate for ID physicians: the long-game compounding strategy
Lower income means slower portfolio building, but the principles still work. Here’s the multi-decade plan for ID physicians.
PSLF for ID physicians: the 501(c)(3) and academic opportunity
Academic ID is one of the cleanest PSLF eligibility cases. Here’s how to make sure you don’t sabotage the 10-year clock.
Tax planning for infectious disease physicians: optimization on a lower income
ID is one of the lowest-paid medical specialties. The tax planning matters more, not less. Here’s the playbook for income-modest, mission-driven…
Referral pulse and growth for heme/onc practices
Hematology practices often miss inbound referrals from PCPs and surgical specialties. Here’s how to measure and capture them.
AI tools for hematology: anticoagulation, peripheral smear, and CDS
Heme AI is moving fast in peripheral smear interpretation, anticoag dosing, and CDS. Here’s the tool directory.
Real estate for hematologists: the depreciation play for high-K-1 income
K-1 income from infusion practices shields differently than W-2. Here’s how real estate depreciation interacts with practice income.
Tax planning for hematologists with practice equity
If you’re a heme partner with K-1 income, the tax structure is different. Here’s the optimization for partnership-track hematologists.
Buy-and-bill economics for hematology: why PE is rolling up your specialty
Hematology infusion margins are why private equity has been acquiring heme/onc practices. Here’s the economics PE sees and how to evaluate a sale offer.